Table 1.
% Inhibtion |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Serotypes | C1 | C2 | C3 | C4 | C5 | C6 | C7 | C8 | C9 | C10 | Sources |
O78 | 84 | 92 | 78 | 75 | 83 | 92 | 94 | 98 | 79 | 84 | [62] |
O2 | 94 | 96 | 54 | 76 | 89 | 93 | 83 | 94 | 51 | 89 | [63] |
O1 | 76 | 64 | 65 | 63 | 46 | 93 | 47 | 41 | 19 | 64 | [4] |
O8 | 20 | 20 | 39 | 0 | 18 | 79 | 2 | 18 | 20 | 0 | [63] |
O15 | 13 | 27 | 0 | 46 | 45 | 97 | 36 | 25 | 0 | 22 | [63] |
O18 | 37 | 43 | 8 | 54 | 61 | 95 | 48 | 54 | 14 | 35 | [63] |
O35 | 48 | 55 | 37 | 60 | 68 | 96 | 62 | 57 | 36 | 47 | [63] |
O109 | 65 | 57 | 0 | 67 | 69 | 60 | 67 | 75 | 66 | 57 | [63] |
O115 | 64 | 52 | 35 | 58 | 63 | 99 | 45 | 44 | 44 | 78 | [63] |
Inhibition of AI-2 activity was calculated by comparing bioluminescence inhibition from SM treated APEC O78 culture with that of the DMSO treated control